Pullen, D J <br/><br/>
Pediatric oncology group utilization of immunologic markers in the designation of acute lymphocytic leukemia subgroups: influence on treatment response.  [electronic resource] 

 -  Annals of the New York Academy of Sciences  1984 
 - 26-48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0077-8923 
<br/><br/><label>Standard No.: </label>10.1111/j.1749-6632.1984.tb12280.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Neoplasm--analysis<br/>Bone Marrow--immunology<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Female<br/>Histocompatibility Antigens Class II--analysis<br/>Humans<br/>Immunoglobulin Fab Fragments--analysis<br/>Infant<br/>Leukemia, Lymphoid--classification<br/>Male<br/>Neprilysin<br/>Prognosis